Gene Expression Signature in Adipose Tissue of Acromegaly Patients.

mrc2admin's picture
Tue, 2015-09-15 14:22 -- mrc2admin
TitleGene Expression Signature in Adipose Tissue of Acromegaly Patients.
Publication TypeJournal Article
Year of Publication2015
AuthorsHochberg I, Tran QT, Barkan AL, Saltiel AR, Chandler WF, Bridges D
JournalPLoS One
Volume10
Issue6
Paginatione0129359
Date Published2015
ISSN1932-6203
Abstract

To study the effect of chronic excess growth hormone on adipose tissue, we performed RNA sequencing in adipose tissue biopsies from patients with acromegaly (n = 7) or non-functioning pituitary adenomas (n = 11). The patients underwent clinical and metabolic profiling including assessment of HOMA-IR. Explants of adipose tissue were assayed ex vivo for lipolysis and ceramide levels. Patients with acromegaly had higher glucose, higher insulin levels and higher HOMA-IR score. We observed several previously reported transcriptional changes (IGF1, IGFBP3, CISH, SOCS2) that are known to be induced by GH/IGF-1 in liver but are also induced in adipose tissue. We also identified several novel transcriptional changes, some of which may be important for GH/IGF responses (PTPN3 and PTPN4) and the effects of acromegaly on growth and proliferation. Several differentially expressed transcripts may be important in GH/IGF-1-induced metabolic changes. Specifically, induction of LPL, ABHD5, and NRIP1 can contribute to enhanced lipolysis and may explain the elevated adipose tissue lipolysis in acromegalic patients. Higher expression of TCF7L2 and the fatty acid desaturases FADS1, FADS2 and SCD could contribute to insulin resistance. Ceramides were not different between the two groups. In summary, we have identified the acromegaly gene expression signature in human adipose tissue. The significance of altered expression of specific transcripts will enhance our understanding of the metabolic and proliferative changes associated with acromegaly.

DOI10.1371/journal.pone.0129359
Alternate JournalPLoS ONE
PubMed ID26087292
PubMed Central IDPMC4472931
Grant ListU24 DK097153 / DK / NIDDK NIH HHS / United States